FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Metaproterenol Sulfate Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Pulmonary/Allergy

Expand all

Par Pharmaceutical (New 07/12/2019)

Company Contact Information:
800-828-9393 option 5, then option 2

Presentation Posting Date Related Information
10mg, 100 count (NDC 49884-0258-01) 07/12/2019 Business decision to discontinue marketing in the US.
20mg, 100 count (NDC 49884-0259-01) 07/12/2019 Business decision to discontinue marketing in the US.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English